Interpretation of clinical trials comparing different drug regimens for Parkinson's disease (PD) is complicated by the different dose intensities used: higher doses of levodopa and, possibly, other drugs produce better symptomatic control but more late complications. To address this problem, convers...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!